Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jun 1;5(6):e2218986.
doi: 10.1001/jamanetworkopen.2022.18986.

Association of Prepregnancy Body Mass Index With Risk of Severe Maternal Morbidity and Mortality Among Medicaid Beneficiaries

Heather A Frey  1 , Robert Ashmead  2 , Alyssa Farmer  2 , Yoshie H Kim  2 , Cynthia Shellhaas  1   3 , Reena Oza-Frank  3 , Rebecca D Jackson  4 , Maged M Costantine  1 , Courtney D Lynch  1
Affiliations

Association of Prepregnancy Body Mass Index With Risk of Severe Maternal Morbidity and Mortality Among Medicaid Beneficiaries

Heather A Frey et al. JAMA Netw Open. .

Abstract

Importance: The association between body mass index (BMI, which is calculated as weight in kilograms divided by height in meters squared) and severe maternal morbidity (SMM) and/or mortality is uncertain, judging from the current evidence.

Objective: To examine the association between prepregnancy BMI and SMM and/or mortality through 1 year post partum and to identify both the direct and indirect implications of maternal obesity for SMM and/or mortality by examining hypertensive disorders and pregestational diabetes as potential mediators.

Design, setting, and participants: This population-based cohort study was conducted from March to October 2021 using the vital records and linked Medicaid claims data in the state of Ohio from January 1, 2012, through December 31, 2017. The cohort comprised pregnant Medicaid beneficiaries who delivered at 20 weeks' gestation or later and had prepregnancy BMI information.

Exposures: The primary exposure was maternal prepregnancy BMI, which was categorized as follows: underweight (<18.5), healthy weight (18.5-24.9), overweight (25.0-29.9), class 1 obesity (30.0-34.9), class 2 obesity (35.0-39.9), and class 3 obesity (≥40.0).

Main outcomes and measures: The primary outcome was a composite of SMM (defined using Centers for Disease Control and Prevention criteria) and/or maternal mortality between 20 weeks' gestation and 1 year post partum. Additional periods were assessed, including 20 weeks' gestation through delivery hospitalization and 20 weeks' gestation through 42 days post partum. Generalized estimating equation models were used to estimate adjusted relative risks (aRRs) for the primary outcome according to BMI category. Maternal hypertensive diseases and pregestational diabetes were assessed as potential meditators.

Results: In a cohort of 347 497 pregnancies among 276 691 Medicaid beneficiaries (median [IQR] maternal age at delivery, 25 [21-29] years; 210 470 non-Hispanic White individuals [60.6%]), the prevalence of maternal obesity was 30.5% (n = 106 031). Composite SMM and/or mortality outcome occurred in 5.3% of pregnancies (n = 18 398). Overweight (aRR, 1.07; 95% CI, 1.03-1.11) and obesity (class 1: aRR, 1.19 [95% CI, 1.14-1.24]; class 2: aRR, 1.37 [95% CI, 1.30-1.44]; class 3: aRR, 1.71 [95% CI, 1.63-1.80]) were associated with an elevated risk of SMM and/or mortality during pregnancy to 1 year post partum compared with healthy BMI. Similar findings were observed when the follow-up period was shortened to 42 days post partum or the delivery hospitalization. Hypertension mediated 65.1% (95% CI, 64.6%-65.6%) of the association between obesity and the primary outcome.

Conclusions and relevance: Results of this study showed that maternal prepregnancy obesity was associated with an elevated risk of SMM and/or mortality. Hypertensive disorders appeared to mediate this association, suggesting that improved prevention and management of hypertensive disorders in pregnancy may reduce morbidity and mortality in individuals with obesity.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosures: Dr Jackson reported receiving grants from the National Institutes of Health (NIH) during the conduct of the study and outside the submitted work. Dr Costantine reported receiving grants from the NIH, AMAG Pharmaceuticals Inc, and Baxter Inc and personal fees from Progenity, Momenta, and ObsEva outside the submitted work. No other disclosures were reported.

Figures

Figure.
Figure.. Study Flow Diagram
BMI indicates body mass index; PAMR, Pregnancy-Associated Mortality Review.
See this image and copyright information in PMC

References

    1. Driscoll AK, Gregory ECW. Increases in prepregnancy obesity: United States, 2016-2019. NCHS Data Brief. 2020;(392):1-8. - PubMed
    1. Chu SY, Callaghan WM, Kim SY, et al. . Maternal obesity and risk of gestational diabetes mellitus. Diabetes Care. 2007;30(8):2070-2076. doi:10.2337/dc06-2559a - DOI - PubMed
    1. Najafi F, Hasani J, Izadi N, et al. . The effect of prepregnancy body mass index on the risk of gestational diabetes mellitus: a systematic review and dose-response meta-analysis. Obes Rev. 2019;20(3):472-486. doi:10.1111/obr.12803 - DOI - PubMed
    1. Weiss JL, Malone FD, Emig D, et al. ; FASTER Research Consortium . Obesity, obstetric complications and cesarean delivery rate—a population-based screening study. Am J Obstet Gynecol. 2004;190(4):1091-1097. doi:10.1016/j.ajog.2003.09.058 - DOI - PubMed
    1. Paré E, Parry S, McElrath TF, Pucci D, Newton A, Lim KH. Clinical risk factors for preeclampsia in the 21st century. Obstet Gynecol. 2014;124(4):763-770. doi:10.1097/AOG.0000000000000451 - DOI - PubMed

Publication types